NDTV Profit on MSN
Moderna Shares Jump 5%: Why Hantavirus Scare Is Booster Dose For Wall Street's Pharma Majors
Pharma and biotech stocks rallied after the WHO flagged a hantavirus outbreak linked to a cruise ship, reviving investor bets ...
Achieved Q1 2026 PEMGARDA® (pemivibart) net product revenue of $13.7 million, representing 22% growth versus Q1 2025 net product revenue of $11.3 ...
CAMBRIDGE, MA / ACCESS Newswire / September 16, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced positive preliminary immunogenicity data for the 2025-2026 formula of Spikevax®, which targets the LP ...
Read oxford vaccine latest news on The Economic Times. oxford vaccine updates, oxford vaccine developments, videos and more.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results